RP Management
Latest statistics and disclosures from RP Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are BHVN, BCRX, VIRX, and represent 100.00% of RP Management's stock portfolio.
- RP Management has $180M in assets under management (AUM), dropping by 73.86%.
- Central Index Key (CIK): 0001507673
Tip: Access up to 7 years of quarterly data
Positions held by RP Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for RP Management
RP Management holds 3 positions in its portfolio as reported in the March 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Biohaven (BHVN) | 89.2 | $161M | 2.9M | 54.69 |
|
|
| BioCryst Pharmaceuticals (BCRX) | 10.8 | $20M | 3.8M | 5.08 |
|
|
| Viracta Therapeutics (VIRX) | 0.0 | $3.8k | 3.7k | 1.02 |
|
Past Filings by RP Management
SEC 13F filings are viewable for RP Management going back to 2018
- RP Management 2024 Q1 filed May 8, 2024
- RP Management 2023 Q3 filed Nov. 13, 2023
- RP Management 2023 Q2 filed Aug. 11, 2023
- RP Management 2023 Q1 filed May 15, 2023
- RP Management 2022 Q4 filed Feb. 14, 2023
- RP Management 2022 Q3 filed Nov. 14, 2022
- RP Management 2022 Q2 filed Aug. 10, 2022
- RP Management 2022 Q1 filed May 11, 2022
- RP Management 2021 Q4 filed Feb. 14, 2022
- RP Management 2021 Q3 filed Nov. 15, 2021
- RP Management 2021 Q2 filed Aug. 12, 2021
- RP Management 2021 Q1 filed May 17, 2021
- RP Management 2020 Q4 filed Feb. 16, 2021
- RP Management 2020 Q3 filed Nov. 12, 2020
- RP Management 2020 Q2 filed Aug. 14, 2020
- RP Management 2020 Q1 filed May 15, 2020